Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging

Clinical trial NCT00709852 · COMPLETED

Trial details

NCT number: NCT00709852
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diagnostic Imaging Central Nervous System Diseases

Start date: 2008-06-01
Primary completion: 2009-04-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.